Switch theme
Sign up to access all valuation multiples
Prostalund AB is a medical technology company engaged in development of products and treatments in urology.
1991
8
Last FY Revenue $1.4M
Last FY EBITDA -$2.3M
-$0.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Prostalund achieved revenue of $1.4M and an EBITDA of -$2.3M.
Prostalund expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Prostalund valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.4M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.9M | XXX | XXX | XXX |
| Gross Margin | XXX | 65% | XXX | XXX | XXX |
| EBITDA | XXX | -$2.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -164% | XXX | XXX | XXX |
| EBIT | XXX | -$2.3M | XXX | XXX | XXX |
| EBIT Margin | XXX | -164% | XXX | XXX | XXX |
| Net Profit | XXX | -$2.3M | XXX | XXX | XXX |
| Net Margin | XXX | -165% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Prostalund's stock price is SEK 1 (or $0).
Prostalund has current market cap of SEK 3.9M (or $0.4M), and EV of -SEK 3.0M (or -$0.3M).
See Prostalund trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| -$0.3M | $0.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Prostalund has market cap of $0.4M and EV of -$0.3M.
Prostalund's trades at -0.2x EV/Revenue multiple, and 0.1x EV/EBITDA.
Equity research analysts estimate Prostalund's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Prostalund's P/E ratio is not available.
See valuation multiples for Prostalund and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $0.4M | XXX | $0.4M | XXX | XXX | XXX |
| EV (current) | -$0.3M | XXX | -$0.3M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | -0.2x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 0.1x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 0.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialProstalund's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Prostalund's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Prostalund's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Prostalund and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -164% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 113% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 228% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Prostalund acquired XXX companies to date.
Last acquisition by Prostalund was XXXXXXXX, XXXXX XXXXX XXXXXX . Prostalund acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Prostalund founded? | Prostalund was founded in 1991. |
| Where is Prostalund headquartered? | Prostalund is headquartered in Sweden. |
| How many employees does Prostalund have? | As of today, Prostalund has 8 employees. |
| Is Prostalund publicy listed? | Yes, Prostalund is a public company listed on STO. |
| What is the stock symbol of Prostalund? | Prostalund trades under PLUN ticker. |
| When did Prostalund go public? | Prostalund went public in 2013. |
| Who are competitors of Prostalund? | Similar companies to Prostalund include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Prostalund? | Prostalund's current market cap is $0.4M |
| Is Prostalund profitable? | Yes, Prostalund is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
